XML 38 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Operating activities:    
Net income $ 35,790 $ 42,977
Income (loss) from discontinued operations, net of tax (100) 448
Income from continuing operations 35,890 42,529
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 85,380 84,674
Earnings, net of distributions, from equity method investments 1,181 (484)
Deferred income taxes 32,596 34,502
Changes in current assets and liabilities, net of acquisitions:    
Receivables 101,917 50,260
Inventories (38,357) (13,634)
Other current assets (21,556) (18,897)
Accounts payable (29,851) (21,875)
Other current liabilities (33,751) (15,738)
Other noncurrent changes (8,349) (20,510)
Net cash provided by continuing operations 125,100 120,827
Net cash used in discontinued operations (107) (366)
Net cash provided by operating activities 124,993 120,461
Investing activities:    
Capital expenditures (174,429) (82,664)
Acquisitions, net of cash acquired (242) (157)
Net proceeds from sale or disposition of property and other 18,256 10,524
Investments (27) (9,856)
Net cash used in continuing operations (156,442) (82,153)
Net cash provided by discontinued operations 0 0
Net cash used in investing activities (156,442) (82,153)
Financing activities:    
Repayment of short-term borrowings 0 (20,000)
Repayment of long-term debt (8,297) (80,630)
Proceeds from issuance of common stock 88 5,744
Dividends paid (31,794) (30,773)
Excess tax benefit on stock-based compensation 26 1,248
Net cash used in continuing operations (39,977) (124,411)
Net cash provided by discontinued operations 0 0
Net cash used in financing activities (39,977) (124,411)
Effect of exchange rate changes on cash and cash equivalents 43 45
Decrease in cash and cash equivalents (71,383) (86,058)
Cash and cash equivalents - beginning of year 162,772 222,074
Cash and cash equivalents - end of year $ 91,389 $ 136,016